PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 132 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,582,000 | -22.0% | 217,752 | -14.5% | 0.18% | -27.4% |
| Q2 2022 | $14,852,000 | -43.0% | 254,747 | -25.3% | 0.24% | -24.7% |
| Q1 2022 | $26,040,000 | +257.7% | 341,200 | +181.8% | 0.32% | +114.8% |
| Q3 2020 | $7,279,000 | +99.2% | 121,069 | +154.4% | 0.15% | +21.1% |
| Q4 2015 | $3,655,000 | +592.2% | 47,599 | +270.6% | 0.12% | +547.4% |
| Q3 2015 | $528,000 | -44.8% | 12,844 | -5.1% | 0.02% | -42.4% |
| Q2 2015 | $957,000 | -80.2% | 13,532 | -75.1% | 0.03% | -80.4% |
| Q1 2015 | $4,836,000 | -40.2% | 54,434 | -40.3% | 0.17% | -48.5% |
| Q4 2014 | $8,086,000 | +26.4% | 91,198 | +38.2% | 0.33% | +33.6% |
| Q3 2014 | $6,398,000 | +108.3% | 66,009 | +97.4% | 0.24% | +144.0% |
| Q2 2014 | $3,071,000 | +78.5% | 33,434 | -6.6% | 0.10% | +51.5% |
| Q3 2013 | $1,720,000 | +106.0% | 35,780 | +24.2% | 0.07% | +83.3% |
| Q2 2013 | $835,000 | – | 28,797 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |